Written by
This is the 4th edition of our Breast Imaging market report which covers the global breast imaging modality and AI markets, published in November 2023.
The 2023 Breast Imaging report and accompanying dataset helps you to:
- Gain actionable market insights and empower your business growth with accurate sizing data for 28 major markets and key product types (FFDM, analogue, DBT, conventional ultrasound, and ABUS).
- Stay abreast of the evolving guidelines, programs, and legislation in breast cancer screening.
- Benchmark your market position with our vendor market shares, guided by collaboration with the top breast imaging vendors, and gain access to our extensive collection of 35 vendor profiles.
- Evaluate the Breast Imaging market, against challenging technologies such as ultrasound, CT and MRI imaging.
- Align your strategic planning using insights on key competitive developments in the markets, including disruptive technologies, new partnerships and product launches.
- Develop a winning AI strategy leveraging our 5-year forecast, key updates, and clinical trials for breast imaging AI.
This is Signify Research’s 2023 report on Breast Imaging. The report is a component of Signify Research's X-ray Market Intelligence Service.
Breast Imaging for cancer remains one of the most significant issues affecting women’s health globally. However, the COVID-19 pandemic has created a vast backlog of screening cases, with early diagnosis of cancer being missed for many women.
This report evaluates the Breast Imaging market, across all imaging modalities, including
the established mammography and tomosynthesis to technologies that are challenging,
such as ultrasound, CT and MRI imaging. Additionally Signify Research analyses the
machine learning tools that are being utilised to assist with screening, triaging and
provide a higher level of efficiency.
